Cleared Traditional

K896032 - MODIFIED ELISA FOR CHLAMYDIA

K896032 is the FDA 510(k) clearance for MODIFIED ELISA FOR CHLAMYDIA by Fairleigh Dickinson Laboratories, Inc.. It is a Class 1 Chemistry device (product code LJC) cleared through the Traditional 510(k) pathway after a 105-day FDA review.

K896032 · Fairleigh Dickinson Laboratories, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1990
Decision
105d
Days
Class 1
Risk

K896032 is an FDA 510(k) clearance for the MODIFIED ELISA FOR CHLAMYDIA. Classified as Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group) (product code LJC), Class I - General Controls.

Submitted by Fairleigh Dickinson Laboratories, Inc. (Abilene, US). The FDA issued a Cleared decision on January 29, 1990 after a review of 105 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 866.3120 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Fairleigh Dickinson Laboratories, Inc. devices

Submission Details

510(k) Number K896032 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 16, 1989
Decision Date January 29, 1990
Days to Decision 105 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
17d slower than avg
Panel avg: 88d · This submission: 105d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code LJC Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3120
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LJC Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group)

All 47
Devices cleared under the same product code (LJC) and FDA review panel - the closest regulatory comparables to K896032.
CHLAMYDIAZYME DIAGNOSTIC KIT
K900543 · Abbott Laboratories · May 1990
ADD'L USES FOR THE KODAK SURECELL CHLAMYDIA KIT
K900402 · Eastman Kodak Company · Mar 1990
CLEARVIEW CHLAMYDIA
K895280 · Unipath , Ltd. · Jan 1990
KODAK SURECELL CHLAMYDIA TEST KIT (ADD'L USES)
K895505 · Eastman Kodak Company · Jan 1990
CIBA CORNING MAGIC LITE CHLAMYDIA IMMUNOASSAY
K895122 · Ciba Corning Diagnostics Corp. · Oct 1989
ABBOTT TESTPACK CHLAMYDIA
K893676 · Abbott Laboratories · Jul 1989